Deka Bank Deutsche Girozentrale Precigen, Inc. Transaction History

Deka Bank Deutsche Girozentrale

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 28, 2022	BUY	$1.91 - $3.98 $9,168 - $19,104	4,800 Added 10.0%	52,800 $111,000
Q4 2021 Feb 02, 2022	BUY	$3.53 - $5.5 $5,295 - $8,250	1,500 Added 3.23%	48,000 $177,000
Q4 2020 Mar 12, 2021	SELL	$3.75 - $10.56 $9,375 - $26,400	-2,500 Reduced 5.1%	46,500 $458,000
Q3 2020 Oct 29, 2020	BUY	$3.5 - $6.2 $171,500 - $303,800	49,000 New	49,000 $170,000

148

162M

150K

29.5K

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $408M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.